Human IL2/IL-2/lymphokine ORF/cDNA clone-Lentivirus plasmid (NM_000586)
Cat. No.: pGMLP000542
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human IL2/IL-2/lymphokine Lentiviral expression plasmid for IL2 lentivirus packaging, IL2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
IL-2/IL2/IL2/IL-2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000542 |
| Gene Name | IL2 |
| Accession Number | NM_000586 |
| Gene ID | 3558 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 462 bp |
| Gene Alias | IL-2,lymphokine,TCGF |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGTACAGGATGCAACTCCTGTCTTGCATTGCACTAAGTCTTGCACTTGTCACAAACAGTGCACCTACTTCAAGTTCTACAAAGAAAACACAGCTACAACTGGAGCATTTACTGCTGGATTTACAGATGATTTTGAATGGAATTAATAATTACAAGAATCCCAAACTCACCAGGATGCTCACATTTAAGTTTTACATGCCCAAGAAGGCCACAGAACTGAAACATCTTCAGTGTCTAGAAGAAGAACTCAAACCTCTGGAGGAAGTGCTAAATTTAGCTCAAAGCAAAAACTTTCACTTAAGACCCAGGGACTTAATCAGCAATATCAACGTAATAGTTCTGGAACTAAAGGGATCTGAAACAACATTCATGTGTGAATATGCTGATGAGACAGCAACCATTGTAGAATTTCTGAACAGATGGATTACCTTTTGTCAAAGCATCATCTCAACACTGACTTGA |
| ORF Protein Sequence | MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-INN-811 | Pre-Made Efavaleukin Alfa Biosimilar, Fusion Protein targeting IL2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting IL-2/TCGF/lymphokine |
| Target Antibody | GM-Tg-g-T61698-Ab | Anti-IL2/ IL-2/ TCGF functional antibody |
| Target Antigen | GM-Tg-g-T61698-Ag | IL2 protein |
| ORF Viral Vector | pGMLP000542 | Human IL2 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000406 | Human IL2 Adenovirus plasmid |
| ORF Viral Vector | pGMLP-IL-005 | Human IL2 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-IL-088 | Human IL2 Adenovirus plasmid |
| ORF Viral Vector | pGMPC004771 | Human IL2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP000542 | Human IL2 Lentivirus particle |
| ORF Viral Vector | vGMAP000406 | Human IL2 Adenovirus particle |
| ORF Viral Vector | vGMLP-IL-005 | Human IL2 Lentivirus particle |
| ORF Viral Vector | vGMAP-IL-088 | Human IL2 Adenovirus particle |
Target information
| Target ID | GM-T61698 |
| Target Name | IL-2/IL2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
3558 |
| Gene ID |
100034204 (Equus caballus), 116562 (Rattus norvegicus), 16183 (Mus musculus), 280822 (Bos taurus) 3558 (Homo sapiens), 403989 (Canis lupus familiaris), 708017 (Macaca mulatta), 751114 (Felis catus) |
| Gene Symbols & Synonyms | IL2,Il2,IL-2,TCGF,Il-2,lymphokine |
| Target Alternative Names | IL-2,IL2,Il-2,Il2,Interleukin-2,T-cell growth factor (TCGF),TCGF,lymphokine |
| Uniprot Accession |
P04351,P05016,P17108,P37997,P60568,P68291,Q07885,Q29416
Additional SwissProt Accessions: P37997,P17108,P04351,P05016,P60568,Q29416,P68291,Q07885 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index |
| Disease | cancer, Chronic Kidney Disease |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Yersinia infection, Chagas disease, Measles, Human T-cell leukemia virus 1 infection, Pathways in cancer, Autoimmune thyroid disease, Inflammatory bowel disease, Allograft rejection, Graft-versus-host disease |
| Gene Ensembl | ENSECAG00000015616, ENSMUSG00000027720, ENSBTAG00000020883, ENSG00000109471, ENSCAFG00845020168, ENSMMUG00000021093 |
| Target Classification | Cytokine Receptor, Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


